We demonstrated that miR‐146a inhibits the pro‐inflammatory chemokines IL‐8, CXCL1, and CCL5, induces the production of IFN‐λ, and has the capacity to limit infection by RV‐A16 in HBECs. This evidence concerns the gene CCL5 and infection.